在脂肪肝炎诊断中的AI:超越显微镜的精度.
Ayesha Ejaz1, Mehreen Mushtaq Ahmed2, Maliha Khalid3
1Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Annals of medicine and surgery (2012)
|November 3, 2025
概括
人工智能 (AI) 与数字病理学相结合,可以对非酒精性脂肪肝炎 (NASH) 进行客观评估. 这项技术对改善肝脏疾病的诊断准确性和患者护理充满希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 数字病理学数字病理学
- 人工智能的人工智能
背景情况:
- 非酒精性脂肪肝炎 (NASH) 是一种进展性肝脏疾病,无法治愈.
- 目前对NASH的组织学诊断面临着诸如变异性和不敏感性等挑战.
研究的目的:
- 探索人工智能与数字病理学集成的潜力,以实现客观的NASH诊断.
- 评估人工智能的能力,以定量评估肥胖症,气球膨胀和纤维化.
主要方法:
- 使用第二波生成/双光子激发 (SHG/TPE) 的光成像.
- 应用人工智能算法来分析疾病标志物的成像数据.
主要成果:
- 人工智能衍生的评估显示,与病理学家分配的成绩有很强的相关性.
- 人工智能提供了对NASH关键特征的定量和可重复评估.
结论:
- 基于人工智能的数字病理学可以提高NASH的诊断精度和可重现性.
- 克服成本和验证等挑战对于人工智能在肝病诊断中的临床转化至关重要.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
526
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
526
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176


